NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea
· Delayed Price · Currency is KRW 1,618.00
-12.00 (-0.74%)
Mar 20, 2025, 9:00 AM KST
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 30.72 billion as of April 1, 2025. Its market cap has decreased by -45.40% in one year.
Market Cap
30.72B
Enterprise Value
32.97B
Revenue
6.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,618.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 30.72B, a decrease of -90.20%. That is a compound annual growth rate of -41.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 30.72B | -5.22% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | 379.90B | 21.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 396.83T |
| SK hynix | 137.33T |
| LG Energy Solution | 83.30T |
| Samsung Biologics | 74.66T |
| Hyundai Motor Company | 44.69T |
| Celltrion | 38.03T |
| Kia Corporation | 37.52T |
| KB Financial Group | 29.19T |